TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $7,832,000 | +2.5% | 7,871,000 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $7,639,000 | -20.7% | 7,871,000 | -20.9% | 0.01% | -27.3% |
| Q2 2020 | $9,638,000 | -43.0% | 9,953,000 | -45.6% | 0.01% | -62.1% |
| Q1 2020 | $16,920,000 | +16.8% | 18,281,000 | +19.6% | 0.03% | +70.6% |
| Q4 2019 | $14,485,000 | -13.8% | 15,281,000 | -17.6% | 0.02% | -32.0% |
| Q3 2019 | $16,797,000 | +4489.3% | 18,550,000 | +4537.5% | 0.02% | – |
| Q2 2019 | $366,000 | -90.2% | 400,000 | -90.1% | 0.00% | -100.0% |
| Q1 2019 | $3,734,000 | +10.3% | 4,050,000 | +8.0% | 0.01% | +66.7% |
| Q4 2018 | $3,384,000 | -3.5% | 3,750,000 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $3,507,000 | +30.5% | 3,750,000 | +29.3% | 0.01% | +25.0% |
| Q2 2018 | $2,688,000 | +5.7% | 2,900,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,542,000 | -9.5% | 2,900,000 | -9.4% | 0.00% | 0.0% |
| Q4 2017 | $2,808,000 | – | 3,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |